NHMRC Clinical Trials Centre partners to digitise cancer research

Latest News

Medidata has announced the National Health and Medical Research Council Clinical Trial Centre (NHMRC CTC), based at the University of Sydney, will use its unified platform and analytics for all major new studies starting in 2018.

The agreement will result in the NHMRC CTC consolidating multiple electronic data capture solutions (EDC) solutions to the Medidata eClinical cloud platform.

This includes the use of Medidata Rave eCOA/ePRO and Medidata Rave EDC, which enable the NHMRC CTC to manage and ingest the widest array of clinical trial data, with the potential to include sensors, mobile apps, genomics and RWE (Real World Evidence).

NHMRC CTC will also improve data quality and risk reduction in randomisation and trial supply management with single-source data from Rave RTSM. These solutions allow streamlined collaboration for researchers across sites and simplify how patients involved in the trials can report their data.

NHMRC CTC trials focus on investigating anti-cancer treatments, novel therapeutics for cardiovascular disease and diabetes, and driving new standards of care in perinatal disease. According to director Professor John Simes, the agreement will help simplify, improve and accelerate their clinical trials.

“Clinical trials underpin discoveries that lead to medical breakthroughs and help determine best medical practice. The NHMRC Clinical Trial Centre enjoys a leading role in these areas,” said Professor Simes. “We’re excited about how this new relationship will help our study teams reduce trial planning and implementation efforts and consolidate costs. With a single, unified eClinical platform, we can streamline our research to realise better health practice through innovative clinical trials."

According to Edwin Ng, vice president of field operations, APeJ from Medidata, “we’re delighted to be partnering with one of the leading clinical research organizations in Australia. This deal is another fundamental step in further supporting Australian researchers and their patients.

''Medidata's unrivalled expertise in Clinical Research on oncology is powering leading research pioneers globally, such as the NHMRC Clinical Trials Centre. I'm excited to see how it fosters further innovation and efficiency for clinical studies in Australia.''